Case File
efta-02390744DOJ Data Set 11OtherEFTA02390744
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02390744
Pages
4
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Tazia Smith <
Sent:
Thursday, October 24, 2013 8:04 PM
To:
[email protected]
Subject:
AAPL... [C]
Classification: Confidential
I wasn't sure whether to be excited or terrified when i read your email this morning! having flashes of that gatica movie
or that speilberg's "A.I."
We're set up on the listed options n=w.
I called you today re: AAPL. Y=ur in-the-money buy-and-write is pricing on top of spot. Let me know if you would like to
work a spread at a limit.
AAPL reports 10/28, stock goes ex on 11/7 (know dividends aren't as attractive to you as appreciation). buy the
rumor/sell the news risk in the stock after its 10% move since 10/7.
Example:
AAPL spot $530.86
Jan 265 puts 264.95 x 267.20
We are almost there with otc derivat=ves/isda - darren is excellent. so far underliers of our pending trades have been
patient for me as far as entry points.
Please let me know if you want to mo=e forward with AAPL or wait.
Best Regards,
Tazia
212-454-2889
917-327-4107
Tazia Smith
Director l Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 26th Floor
New York, NY 10154
EFTA_R1_01416374
EFTA02390744
Mobile +1(917) 327.4107
Email [email protected]
From: Jeffrey Epstein <[email protected]>
To:
Tazia Smith/db/dbcom@DBAMERICAS,
10/24/2013 07:50 AM
Subject:
Re: Many Thanks + Summary (C)=/table>
yesterday at mit i not only saw the genetic manipulation of smells.. but the elctric manipulation of bottles and shape=,
that reflect hapy spicy, sad. etc. wild. also robots that change their voice and manner when they sense you are bored
On Wed, Oct 23, 2013 at 9:51 AM, Tazia Smith c=a href
target=_
Classification: Confidential
Good Morning Jeffrey —
Thank you for the meeting yesterday — fantastic spending time with you and we're excited to get to =ork. Per our
discussion:
(1)
Enter USDMXN "Deposit Plus" (consider a lmo with a 13.20 strike, - 6%.=Indicative levels below)
(2)
USDJPY risk reversal (lyr 97.84(atmf)/90)
(3)
AAPL in the money buy-and-write (earnings on 10/28)
(4)
Buy USD Payer Swaption (or spread)
(5)
Begin profit-taking among long-duration/perpetual preferreds
(6)
Holding ARIA (call option at this point, bellwether for other biotech trades)
(7) WTI option to monetize spike - and reversion! - within limos
Darren and I are finalizing the ISDA. I will refresh levels and call you to trade once that agreement is executed.
Call you on AAPL/listed trades in the interim.
Speak with you soon,
Tazia
2
EFTA_R1_01416375
EFTA02390745
PS. I read the NYT article on yeast e=gineering!
<=1"
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 26th Floor
New York, NY 10154
This communication may contain confidential and/or privileged information.<=r> If you are not the intended recipient
(or have received this communicationar> in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the material in this communication is strictly
forbidden.
Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be
regarded as such.
The information contained in this communication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized
use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you
have received this communication in error, please notify us immediately by return e-mail or by e-mail to
[email protected]</=ont> <mailto:[email protected]=target=_blank> , and destroy this communication and
all copies thereof, including all attachments. copyright -all rights reserved
This communication may contain confid=ntial and/or privileged information.
If you are not the intended recipient (or have received this communicationar> in error) please notify the sender
immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the<=r> material
in this communication is strictly forbidden.
3
EFTA_R1_01416376
EFTA02390746
Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be
regarded as such.
4
EFTA_R1_01416377
EFTA02390747
Technical Artifacts (10)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Phone
+1(917) 327.4107Phone
212-454-2889Phone
2390744Phone
2390745Phone
2390746Phone
2390747Phone
917-327-4107Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.